Financials

  • Market Capitalization 14.64 M
  • Employee 24
  • Founded 2017
  • CEO N/A
  • Website www.passagebio.com
  • Headquarter Delaware, United States
  • FIGI BBG00NBK4XF9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.82
Rapporto prezzo/fatturato
25.52

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4553
PTN
Palatin Technologies, Inc. Common Stock
8.55 USD-0.58%-5.00%-27.05%+17.93%15.23 M USD
4558
KTTA
Pasithea Therapeutics Corp. - Common Stock
0.45 USD-4.26%-4.26%-13.46%-38.36%15.04 M USD
4572
ESLA
Estrella Immunopharma, Inc. - Common Stock
0.33 USD-19.51%-25.00%-54.79%-78.00%14.35 M USD
4574
KZIA
Kazia Therapeutics Limited - American Depositary Shares
8.81 USD-1.34%-7.56%-20.77%+50.60%14.26 M USD

Notizie